Correlation Between Regencell Bioscience and Phibro Animal

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regencell Bioscience and Phibro Animal at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regencell Bioscience and Phibro Animal into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regencell Bioscience Holdings and Phibro Animal Health, you can compare the effects of market volatilities on Regencell Bioscience and Phibro Animal and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regencell Bioscience with a short position of Phibro Animal. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regencell Bioscience and Phibro Animal.

Diversification Opportunities for Regencell Bioscience and Phibro Animal

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between Regencell and Phibro is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Regencell Bioscience Holdings and Phibro Animal Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phibro Animal Health and Regencell Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regencell Bioscience Holdings are associated (or correlated) with Phibro Animal. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phibro Animal Health has no effect on the direction of Regencell Bioscience i.e., Regencell Bioscience and Phibro Animal go up and down completely randomly.

Pair Corralation between Regencell Bioscience and Phibro Animal

Considering the 90-day investment horizon Regencell Bioscience Holdings is expected to generate 4.87 times more return on investment than Phibro Animal. However, Regencell Bioscience is 4.87 times more volatile than Phibro Animal Health. It trades about 0.11 of its potential returns per unit of risk. Phibro Animal Health is currently generating about 0.01 per unit of risk. If you would invest  483.00  in Regencell Bioscience Holdings on August 24, 2024 and sell it today you would earn a total of  82.00  from holding Regencell Bioscience Holdings or generate 16.98% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Regencell Bioscience Holdings  vs.  Phibro Animal Health

 Performance 
       Timeline  
Regencell Bioscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Regencell Bioscience Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Phibro Animal Health 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Phibro Animal Health are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical indicators, Phibro Animal exhibited solid returns over the last few months and may actually be approaching a breakup point.

Regencell Bioscience and Phibro Animal Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regencell Bioscience and Phibro Animal

The main advantage of trading using opposite Regencell Bioscience and Phibro Animal positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regencell Bioscience position performs unexpectedly, Phibro Animal can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phibro Animal will offset losses from the drop in Phibro Animal's long position.
The idea behind Regencell Bioscience Holdings and Phibro Animal Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments